Corrigendum to Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: The RAINBOW analysis [Ann Oncol 26, 2015 2107-2113] (doi: 10.1093/annonc/mdv315)]

S. Bracarda, R. Iacovelli, L. Boni, M. Rizzo, L. Derosa, M. Rossi, L. Galli, G. Procopio, M. Sisani, F. Longo, M. Santoni, F. Morelli, Di Lorenzo G. Di Lorenzo, A. Altavilla, C. Porta, A. Camerini, B. Escudier

Research output: Contribution to journalArticle

Original languageEnglish
Article numbermdv589
Pages (from-to)366
Number of pages1
JournalAnnals of Oncology
Volume27
Issue number2
DOIs
Publication statusPublished - Feb 1 2016

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Bracarda, S., Iacovelli, R., Boni, L., Rizzo, M., Derosa, L., Rossi, M., Galli, L., Procopio, G., Sisani, M., Longo, F., Santoni, M., Morelli, F., G. Di Lorenzo, D. L., Altavilla, A., Porta, C., Camerini, A., & Escudier, B. (2016). Corrigendum to Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: The RAINBOW analysis [Ann Oncol 26, 2015 2107-2113] (doi: 10.1093/annonc/mdv315)]. Annals of Oncology, 27(2), 366. [mdv589]. https://doi.org/10.1093/annonc/mdv589